What is Phillip India unlisted share price?

Overview of Philips India Unlisted Shares:

Philips India, a subsidiary of Royal Philips, a prominent health technology firm dedicated to enhancing people's health and well-being through innovative solutions, has been operating since 1930. Headquartered in Kolkata, it has branches across various states. The company remains actively involved in significant business activities, particularly focusing on multi-modality deals and government tenders with key strategic accounts. In the fiscal year 2022-23, Philips India invested Rs 202 crore in Research and Development (R&D) efforts and Rs 2.84 crore in Corporate Social Responsibility (CSR) initiatives.

Products and Services by Philips India: 

Philips India's unlisted shares offer a wide array of products and services tailored to various needs:

Health Systems provides cutting-edge equipment like the MR 5300 Helium-free 1.5 T MRI and the Spectral CT 7500, known for its premium dual detectors. Additionally, they offer the Afiiniti series—Afiiniti 30, Afiiniti 50, and Afiniti 70—delivering advanced medical solutions.

Under Personal Health, Philips India presents essential grooming tools such as the Beard Trimmer Power adapter, Sonicare electric toothbrushes, and Hair Dryer, alongside innovative products like the Philips Fresh Air Mask for improved personal care.

Innovation Services include AI-based radiology solutions, remote ICU management, cloud-based platforms, and software catering to disease prevention, diagnosis, treatment, and home-based care.

Financial Background and Growth of Philips India Unlisted Shares.

Increase in revenue growth of Philips India Unlisted Shares:

In the years 2021, 2022, and 2023, Philips India saw a steady increase in revenue from operations. Specifically, the revenue figures stood at Rs 4,842.70 crore, Rs 5,481.40 crore, and Rs 5,734.00 crore, respectively. This upward trajectory reflects the company's sustained growth and performance in the market during this period.

Philips India Unlisted Shares and its Corporate Actions: 

In the financial year 2020-21, Philips India Limited distributed a dividend of Rs 3 per share to its shareholders. The following fiscal year, 2021-22, saw a similar dividend payout of Rs 3 per share. Alongside, during the same 2021-22 period, a demerger scheme was implemented starting from July 1, 2021, involving Philips India Limited as the Demerged Company, Philips Domestic Appliances India Limited as the Resulting Company, and Preethi Kitchen Appliances Private Limited as the Amalgamating Company. As part of this arrangement, Philips Domestic Appliances India Limited issued 57,517,242 equity shares valued at Rs 10 each to its members. Furthermore, in the fiscal year 2022-23, Philips India Limited distributed an interim dividend of Rs 222 per share, followed by a final dividend of Rs 3 per share, demonstrating its commitment to shareholders amid corporate restructuring efforts.

Philips India Unlisted Share Price:

The current Philips India Unlisted share price as of 3 April 2024 is at Rs ₹ 958 per share. 

Philips India Unlisted Share Price in Depth 

Face Value of Philips India: ₹ 10

Price per share as of 3 April 2024: ₹ 958

You can check the Current Philips India Share Price at Precize.in  

Price history of Unlisted Shares of Philips India:

Unlisted Shares of Philips India and its Shareholding Pattern:

In the shareholding structure of Philips India's unlisted shares, Koninklijke Philips N.V. (KPNV) holds a substantial 96.13% ownership. The remaining 3.87% is distributed among other stakeholders or entities. 

Financials of Philips India Unlisted Shares.

Balance Sheet of Philips India Unlisted Shares:

Income Statement of Philips India Unlisted Shares:

Growth Opportunities and Challenges for Philips India Unlisted Shares.

Opportunities for Philips India Unlisted Shares Unlisted Shares:

There is increasing demand for healthcare technologies.

Challenges for Philips India Unlisted Shares: 

The medical device industry faces fierce competition from prominent players, alongside grappling with pricing pressures and reimbursement policies dictated by governments, insurance firms, and healthcare providers. These pricing constraints not only impact profitability significantly but also pose hurdles to market entry. Consequently, companies operating in this sector must adeptly navigate these competitive dynamics and devise strategies to tackle pricing and reimbursement challenges effectively.

*Disclaimer: This information is for private use only and does not constitute investment advice. Recipients must assess risks and seek advice from financial, legal, and tax professionals. Private market investments carry risks, and there are no guarantees of returns or capital protection. We are not liable for investment decisions.